A Global Network Driving Innovation in Health and Well-being
A multidisciplinary consortium of leading academic institutions, research centers, healthcare providers, and industry partners, all united by a shared mission: to revolutionize the prevention and management of mild cognitive impairment (MCI) in patients with cardiovascular diseases (CVD).
By integrating expertise from artificial intelligence, neurology, cardiology, digital health, and behavioral sciences, our network composed of 25 partners is uniquely positioned to develop cutting-edge solutions for personalized risk assessment and holistic intervention strategies.
